Approval · Notice of Compliance 1698 · 2001
ZIMAMOX: Notice of Compliance 1698
Issued January 18, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1698
- Date
- January 18, 2001
- Company
- Linson Pharma Co.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZIMAMOX | 02241988 | — |
| ZIMAMOX | 02241989 | — |
| ZIMAMOX | 02241990 | — |
| ZIMAMOX | 02241991 | — |
Medicinal ingredients
- AMOXICILLIN 250 MG per CAP
- AMOXICILLIN 500 MG per CAP
- AMOXICILLIN 125 MG per 5ML
- AMOXICILLIN 250 MG per 5ML